Financials

Discussions Technicals Seasonals

6615 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Sofiva Genomics Co., Ltd. engages in the provision of pre-pregnancy, prenatal, and newborn genetic testing and medical testing services. It specializes in reproductive medicine testing, cancer, pregnant women testing, neonatal testing, rare diseases, and personalized genetic testing. The company was founded by I Ning Su on June 15, 2012 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6615 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company